title: Omalizumab Is Associated with Reduced Acute Severity of Rhinovirus-triggered Asthma Exacerbation.
authors.affiliation: 1 Boston Children's Hospital Boston, Massachusetts.|2 Harvard Medical School Boston, Massachusetts and.
authors.forename: David B
authors.initials: DB
authors.lastname: Kantor
authors.affiliation: 1 Boston Children's Hospital Boston, Massachusetts.
authors.forename: Molly C
authors.initials: MC
authors.lastname: McDonald
authors.affiliation: 1 Boston Children's Hospital Boston, Massachusetts.
authors.forename: Nicole
authors.initials: N
authors.lastname: Stenquist
authors.affiliation: 1 Boston Children's Hospital Boston, Massachusetts.
authors.forename: Blake J
authors.initials: BJ
authors.lastname: Schultz
authors.affiliation: 1 Boston Children's Hospital Boston, Massachusetts.
authors.forename: Craig D
authors.initials: CD
authors.lastname: Smallwood
authors.affiliation: 1 Boston Children's Hospital Boston, Massachusetts.|2 Harvard Medical School Boston, Massachusetts and.
authors.forename: Kyle A
authors.initials: KA
authors.lastname: Nelson
authors.affiliation: 1 Boston Children's Hospital Boston, Massachusetts.|2 Harvard Medical School Boston, Massachusetts and.
authors.forename: Wanda
authors.initials: W
authors.lastname: Phipatanakul
authors.affiliation: 1 Boston Children's Hospital Boston, Massachusetts.|2 Harvard Medical School Boston, Massachusetts and.|3 Broad Institute of Harvard and Massachusetts Institute of Technology Cambridge, Massachusetts.
authors.forename: Joel N
authors.initials: JN
authors.lastname: Hirschhorn
mesh_terms: D000208:Acute Disease; D000293:Adolescent; D018927:Anti-Asthmatic Agents / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy*; D002648:Child; D015331:Cohort Studies; D005260:Female; D006801:Humans; D008297:Male; D000069444:Omalizumab / Q000627:therapeutic use*; D011446:Prospective Studies; D012229:Rhinovirus; D012720:Severity of Illness Index; D016896:Treatment Outcome
chemical_list: D018927:Anti-Asthmatic Agents; D000069444:Omalizumab